Direct Medical Costs Attributable to Acute Myocardial Infarction and Ischemic Stroke in Cohorts with Atherosclerotic Conditions
- 1 July 2004
- journal article
- research article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 18 (1) , 8-15
- https://doi.org/10.1159/000078602
Abstract
Background: The cost of acute ischemic events in persons with established atherosclerotic conditions is unknown. Methods: The direct medical costs attributable to secondary acute myocardial infarction (AMI) or ischemic stroke among persons with established atherosclerotic conditions were estimated from 1995–1998 data on 1,143 patients enrolled in US managed care plans. Results: The average 180-day costs attributable to secondary AMI or stroke were estimated as USD 19,056 in the AMI cohort having a private insurance (commercial; n = 344), USD 16,845 in the AMI cohort having government insurance (Medicare, age ≧65 years; n = 200), USD 10,267 for stroke commercial (n = 108), USD 16,280 for stroke Medicare (n = 113), USD 15,224 for peripheral arterial disease commercial (n = 170), and USD 15,182 for peripheral arterial disease Medicare (n = 208). Conclusion: These estimates can be used to study the cost-effectiveness of interventions proven to reduce these secondary events.Keywords
This publication has 12 references indexed in Scilit:
- CAPTOPRIL IN THE MANAGEMENT OF PATIENTS AFTER ACUTE MYOCARDIAL INFARCTIONS. A COST EFFECTIVENESS ANALYSIS IN ITALYPharmacological Research, 1998
- Cost of Cardiac Care in the Three Years After Coronary Catheterization in a Contained Care System: Critical Determinants and Implications 11Financial support of this project was provided by the Office of Quality Management, The Cleveland Clinic Foundation, Cleveland, Ohio.Journal of the American College of Cardiology, 1998
- Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass SurgeryNew England Journal of Medicine, 1997
- Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarctionPublished by American Medical Association (AMA) ,1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery DiseaseThe American Journal of Cardiology, 1996
- Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular ProjectPublished by American Medical Association (AMA) ,1995
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reductionThe American Journal of Cardiology, 1991
- Determinants of hospital charges for coronary artery bypass surgery: The economic consequences of postoperative complicationsThe American Journal of Cardiology, 1990
- Medical costs of coronary artery disease in the United StatesThe American Journal of Cardiology, 1990